دورية أكاديمية
أعرض في EDS

Development of a genetically encoded sensor for probing endogenous nociceptin opioid peptide release.

التفاصيل البيبلوغرافية
العنوان: Development of a genetically encoded sensor for probing endogenous nociceptin opioid peptide release.
المؤلفون: Zhou X; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland.; Neuroscience Center Zurich, University and ETH Zürich, Zürich, Switzerland., Stine C; Center for the Neurobiology of Addiction, Pain, and Emotion, University of Washington, Seattle, WA, USA.; Departments of Anesthesiology and Pharmacology and Bioengineering, University of Washington, Seattle, WA, USA.; Molecular and Cellular Biology, University of Washington School of Medicine, Seattle, WA, USA., Prada PO; Max Planck Institute for Metabolism Research, Cologne, Germany.; Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD) and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; School of Applied Sciences, State University of Campinas (UNICAMP), Limeira, Sao Paulo, Brazil., Fusca D; Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD) and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; Institute of Zoology, Department of Biology, University of Cologne, Cologne, Germany., Assoumou K; Department of Cell Physiology and Metabolism, University of Geneva, Geneva, Switzerland., Dernic J; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland., Bhat MA; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland., Achanta AS; Center for the Neurobiology of Addiction, Pain, and Emotion, University of Washington, Seattle, WA, USA.; Departments of Anesthesiology and Pharmacology and Bioengineering, University of Washington, Seattle, WA, USA., Johnson JC; Center for the Neurobiology of Addiction, Pain, and Emotion, University of Washington, Seattle, WA, USA.; Departments of Anesthesiology and Pharmacology and Bioengineering, University of Washington, Seattle, WA, USA., Pasqualini AL; Center for the Neurobiology of Addiction, Pain, and Emotion, University of Washington, Seattle, WA, USA.; Departments of Anesthesiology and Pharmacology and Bioengineering, University of Washington, Seattle, WA, USA., Jadhav S; Center for the Neurobiology of Addiction, Pain, and Emotion, University of Washington, Seattle, WA, USA.; Departments of Anesthesiology and Pharmacology and Bioengineering, University of Washington, Seattle, WA, USA., Bauder CA; Max Planck Institute for Metabolism Research, Cologne, Germany.; Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD) and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany., Steuernagel L; Max Planck Institute for Metabolism Research, Cologne, Germany.; Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD) and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany., Ravotto L; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland., Benke D; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland.; Neuroscience Center Zurich, University and ETH Zürich, Zürich, Switzerland., Weber B; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland.; Neuroscience Center Zurich, University and ETH Zürich, Zürich, Switzerland., Suko A; Center for the Neurobiology of Addiction, Pain, and Emotion, University of Washington, Seattle, WA, USA.; Departments of Anesthesiology and Pharmacology and Bioengineering, University of Washington, Seattle, WA, USA., Palmiter RD; Center for the Neurobiology of Addiction, Pain, and Emotion, University of Washington, Seattle, WA, USA.; Howard Hughes Medical Institute and Departments of Biochemistry and Genome Sciences, University of Washington, Seattle, WA, 98195, USA., Stoeber M; Department of Cell Physiology and Metabolism, University of Geneva, Geneva, Switzerland., Kloppenburg P; Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD) and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; Institute of Zoology, Department of Biology, University of Cologne, Cologne, Germany., Brüning JC; Max Planck Institute for Metabolism Research, Cologne, Germany.; Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD) and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; Policlinic for Endocrinology, Diabetes and Preventive Medicine (PEDP), University Hospital Cologne, Cologne, Germany., Bruchas MR; Center for the Neurobiology of Addiction, Pain, and Emotion, University of Washington, Seattle, WA, USA. mbruchas@uw.edu.; Departments of Anesthesiology and Pharmacology and Bioengineering, University of Washington, Seattle, WA, USA. mbruchas@uw.edu.; Molecular and Cellular Biology, University of Washington School of Medicine, Seattle, WA, USA. mbruchas@uw.edu., Patriarchi T; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland. patriarchi@pharma.uzh.ch.; Neuroscience Center Zurich, University and ETH Zürich, Zürich, Switzerland. patriarchi@pharma.uzh.ch.
المصدر: Nature communications [Nat Commun] 2024 Jun 25; Vol. 15 (1), pp. 5353. Date of Electronic Publication: 2024 Jun 25.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [London] : Nature Pub. Group
مواضيع طبية MeSH: Opioid Peptides*/metabolism , Nociceptin* , Receptors, Opioid*/metabolism , Receptors, Opioid*/genetics , Neurons*/metabolism, Animals ; Humans ; Mice ; Male ; Ventral Tegmental Area/metabolism ; Nociceptin Receptor ; HEK293 Cells ; Brain/metabolism ; Mice, Inbred C57BL ; Ligands ; Biosensing Techniques/methods
مستخلص: Nociceptin/orphanin-FQ (N/OFQ) is a recently appreciated critical opioid peptide with key regulatory functions in several central behavioral processes including motivation, stress, feeding, and sleep. The functional relevance of N/OFQ action in the mammalian brain remains unclear due to a lack of high-resolution approaches to detect this neuropeptide with appropriate spatial and temporal resolution. Here we develop and characterize NOPLight, a genetically encoded sensor that sensitively reports changes in endogenous N/OFQ release. We characterized the affinity, pharmacological profile, spectral properties, kinetics, ligand selectivity, and potential interaction with intracellular signal transducers of NOPLight in vitro. Its functionality was established in acute brain slices by exogeneous N/OFQ application and chemogenetic induction of endogenous N/OFQ release from PNOC neurons. In vivo studies with fibre photometry enabled direct recording of NOPLight binding to exogenous N/OFQ receptor ligands, as well as detection of endogenous N/OFQ release within the paranigral ventral tegmental area (pnVTA) during natural behaviors and chemogenetic activation of PNOC neurons. In summary, we show here that NOPLight can be used to detect N/OFQ opioid peptide signal dynamics in tissue and freely behaving animals.
(© 2024. The Author(s).)
التعليقات: Update of: bioRxiv. 2024 May 22:2023.05.26.542102. doi: 10.1101/2023.05.26.542102. (PMID: 37292957)
References: Front Neurosci. 2012 Sep 25;6:137. (PMID: 23055953)
J Neurochem. 2008 Oct;107(2):544-56. (PMID: 18717817)
Peptides. 2000 Jul;21(7):907-17. (PMID: 10998524)
J Comp Neurol. 2002 Mar 18;444(4):358-68. (PMID: 11891648)
Br J Pharmacol. 2002 Dec;137(8):1355-61. (PMID: 12466246)
Mol Pharmacol. 2013 May;83(5):907-18. (PMID: 23395957)
Cell. 2015 Jul 30;162(3):635-47. (PMID: 26232229)
Neuropsychopharmacology. 2008 Mar;33(4):877-91. (PMID: 17522627)
Neuron. 2019 Jun 5;102(5):1037-1052.e7. (PMID: 31029403)
Nature. 1995 Oct 12;377(6549):532-5. (PMID: 7566152)
Neuron. 2022 Mar 2;110(5):770-782.e5. (PMID: 34942116)
eNeuro. 2020 Oct 19;7(5):. (PMID: 32747458)
Bioorg Med Chem. 2014 Apr 15;22(8):2508-16. (PMID: 24657054)
Cell. 2014 Jun 19;157(7):1535-51. (PMID: 24949967)
Neuropsychopharmacology. 2013 Nov;38(12):2484-97. (PMID: 23787819)
Trends Analyt Chem. 2003 Sep;22(8):522-527. (PMID: 16755306)
Psychopharmacology (Berl). 2001 Feb;154(1):1-7. (PMID: 11291998)
Neuropsychopharmacology. 2007 Apr;32(4):902-10. (PMID: 16880770)
Elife. 2016 Mar 24;5:. (PMID: 27011354)
Nat Rev Neurosci. 2022 May;23(5):257-274. (PMID: 35361961)
J Biol Chem. 2012 Dec 7;287(50):42019-30. (PMID: 23086955)
Neuron. 2020 Oct 14;108(1):17-32. (PMID: 33058762)
Nat Rev Neurosci. 2004 Jun;5(6):483-94. (PMID: 15152198)
Nat Methods. 2020 Nov;17(11):1139-1146. (PMID: 32989318)
Br J Pharmacol. 2002 Jul;136(5):764-72. (PMID: 12086986)
Elife. 2018 Sep 03;7:. (PMID: 30175957)
Peptides. 2000 Jul;21(7):1125-30. (PMID: 10998547)
Nat Methods. 2022 Feb;19(2):231-241. (PMID: 35145320)
Trends Neurosci. 2022 Dec;45(12):899-912. (PMID: 36257845)
Peptides. 2000 Jul;21(7):1071-80. (PMID: 10998542)
Neuron. 2020 Jun 17;106(6):1009-1025.e10. (PMID: 32302532)
Neuron. 2012 Oct 4;76(1):98-115. (PMID: 23040809)
Pharmacol Rev. 2016 Apr;68(2):419-57. (PMID: 26956246)
Cell. 2018 Jul 12;174(2):481-496.e19. (PMID: 30007419)
Elife. 2023 Jun 02;12:. (PMID: 37265064)
Neuroscience. 1996 Nov;75(1):1-4. (PMID: 8923516)
Cell. 2019 Jul 25;178(3):653-671.e19. (PMID: 31348890)
Curr Drug Targets. 2007 Jan;8(1):117-35. (PMID: 17266536)
Addict Neurosci. 2022 Jun;2:. (PMID: 35693759)
Nature. 2012 May 16;485(7398):395-9. (PMID: 22596163)
Neuroreport. 2002 Jun 12;13(8):1051-6. (PMID: 12060807)
Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14854-8. (PMID: 9405703)
J Pharmacol Exp Ther. 2008 Aug;326(2):672-82. (PMID: 18492950)
Cell Rep. 2020 Nov 10;33(6):108362. (PMID: 33176134)
Nat Metab. 2021 Dec;3(12):1662-1679. (PMID: 34931084)
Prog Neuropsychopharmacol Biol Psychiatry. 2015 Oct 1;62:45-50. (PMID: 25724763)
Neuropsychopharmacology. 2017 Feb;42(3):695-706. (PMID: 27562376)
Neuropeptides. 2009 Dec;43(6):507-14. (PMID: 19720395)
Handb Exp Pharmacol. 2019;254:187-212. (PMID: 30968214)
Proc Natl Acad Sci U S A. 2023 Mar 28;120(13):e2214171120. (PMID: 36947514)
Proc Natl Acad Sci U S A. 2023 Apr 4;120(14):e2212387120. (PMID: 36996110)
Science. 1995 Nov 3;270(5237):792-4. (PMID: 7481766)
Science. 2013 Apr 12;340(6129):211-6. (PMID: 23580530)
Results Probl Cell Differ. 2008;46:1-25. (PMID: 18193175)
FEBS Lett. 2003 Jul 3;546(1):65-72. (PMID: 12829238)
Nat Methods. 2020 Nov;17(11):1147-1155. (PMID: 32895537)
Analyst. 2015 Jun 7;140(11):3696-708. (PMID: 25876757)
J Neurosci. 2014 Jan 8;34(2):363-72. (PMID: 24403138)
J Neuroendocrinol. 2003 Jan;15(1):69-74. (PMID: 12535171)
Cell. 2023 Jan 19;186(2):413-427.e17. (PMID: 36638794)
J Comp Neurol. 1999 Apr 19;406(4):503-47. (PMID: 10205026)
Neuropsychopharmacology. 2016 Jun;41(7):1803-12. (PMID: 26585287)
Nat Rev Neurosci. 2016 Mar;17(3):183-95. (PMID: 26865020)
PLoS One. 2015 Aug 06;10(8):e0132865. (PMID: 26248189)
Neuron. 2018 May 16;98(4):707-717.e4. (PMID: 29731250)
Front Cell Neurosci. 2020 Mar 20;14:67. (PMID: 32265667)
Neuroscience. 2003;121(3):629-40. (PMID: 14568023)
Neuropsychopharmacology. 2021 Nov;46(12):2043-2047. (PMID: 33603136)
Handb Exp Pharmacol. 2019;254:259-278. (PMID: 30430261)
Science. 2018 Jun 29;360(6396):. (PMID: 29853555)
Neuropsychopharmacology. 2002 Aug;27(2):203-11. (PMID: 12093594)
Alcohol Clin Exp Res. 2016 May;40(5):945-54. (PMID: 27084498)
Elife. 2023 Aug 09;12:. (PMID: 37555578)
Pharmacol Ther. 2014 Mar;141(3):283-99. (PMID: 24189487)
Nat Biotechnol. 2023 Jul;41(7):944-957. (PMID: 36593404)
Transl Psychiatry. 2018 Feb 2;8(1):38. (PMID: 29391391)
Nat Methods. 2023 Sep;20(9):1426-1436. (PMID: 37474807)
معلومات مُعتمدة: F31 DA059438 United States DA NIDA NIH HHS; P50 MH119467 United States MH NIMH NIH HHS; 310030_196455 Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation)
المشرفين على المادة: 0 (Opioid Peptides)
7AYI9N34FF (Nociceptin)
0 (Receptors, Opioid)
0 (Nociceptin Receptor)
0 (Ligands)
تواريخ الأحداث: Date Created: 20240625 Date Completed: 20240625 Latest Revision: 20240712
رمز التحديث: 20240712
مُعرف محوري في PubMed: PMC11199706
DOI: 10.1038/s41467-024-49712-0
PMID: 38918403
قاعدة البيانات: MEDLINE
الوصف
تدمد:2041-1723
DOI:10.1038/s41467-024-49712-0